As the Fed continues raising rates to fight inflation, investors lean away from rate-sensitive stocks due to higher borrowing costs and softer consumer spending. This environment tends to pressure sectors like utilities and real estate, and a set of five equities across REITs, energy, consumer staples, and pharma are highlighted as less attractive. The assessment points to outcomes driven by leverage, valuation, currency headwinds, and competitive dynamics that could curb earnings and dividends. The takeaway is a cautious stance with potential sector rotation as rates rise and the macro backdrop evolves.
Dive Deeper:
Annaly Capital Management is a REIT focused on mortgage-backed securities; its funding costs rise with higher short-term rates, which can squeeze profitability and potentially reduce dividend payouts.
Breitburn Energy Partners, an oil and gas MLP, has seen a steep stock decline with a high dividend yield, but its heavy debt load and sensitivity to oil prices make it vulnerable in a rising-rate environment.
The Clorox Company trades with a high price-to-earnings ratio relative to its history, and limited growth prospects amid rate hikes, reducing its appeal for investors shifting away from rate-sensitive bets.
Procter & Gamble, though a dividend aristocrat, faces modest dividend increases and headwinds from a strong U.S. dollar on international sales, which can dampen stock performance as rates rise.
GlaxoSmithKline carries a high dividend payout and faces intensified competition for key products; in a rising-rate world, these factors may strain financials and weigh on the stock.